Instead of injecting a peptide that is presented to an APC, autologous dendritic cells sourced from peripheral blood monocytes are primed with tumour lysate from the patients’ own tumour in the presence of growth factors such as interleukin-4 and granulocyte macrophage colony stimulating factor, [79]. The gene discussed is IL4; the disease is neoplasm.